Clin, Cosmet Investig Dermatol
These patients represent a very small proportion of the population (approximately 1 of 200,000 individuals in the world) and have very severe hyperhomocysteinemia that can reach 400 mol/L
For comparison, the GHK-Cu discontinuation guide discusses how stopping other peptide treatments affects maintained results, providing a framework for thinking about long-term treatment commitment
In some embodiments, the otic pharmaceutical formulation has triglycerides in an amount that is sufficient to provide sufficient retention time in the ear
Rafael-Vidal C, Altabas I, Perez N, Mourino Rodriguez C, Pego-Reigosa JM, Garcia S (2021) Calcineurin and systemic lupus erythematosus: the rationale for using calcineurin inhibitors in the treatment of lupus nephritis